Free Trial

Arteris, Inc. (NASDAQ:AIP) Director Sells $24,024.00 in Stock

Arteris logo with Computer and Technology background

Arteris, Inc. (NASDAQ:AIP - Get Free Report) Director Saiyed Atiq Raza sold 2,400 shares of the business's stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $10.01, for a total transaction of $24,024.00. Following the completion of the sale, the director now directly owns 843,842 shares in the company, valued at $8,446,858.42. This trade represents a 0.28 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Arteris Price Performance

Shares of Arteris stock traded up $0.15 during trading on Friday, reaching $10.29. The company's stock had a trading volume of 493,149 shares, compared to its average volume of 166,465. Arteris, Inc. has a one year low of $4.83 and a one year high of $10.60. The stock has a 50-day moving average price of $8.00 and a two-hundred day moving average price of $7.83. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $413.45 million, a P/E ratio of -10.72 and a beta of 1.25.

Institutional Investors Weigh In On Arteris

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Bank of New York Mellon Corp acquired a new stake in shares of Arteris in the 2nd quarter valued at approximately $580,000. Dynamic Technology Lab Private Ltd bought a new stake in Arteris in the third quarter valued at approximately $226,000. Vanguard Group Inc. raised its holdings in Arteris by 0.3% in the first quarter. Vanguard Group Inc. now owns 1,146,224 shares of the company's stock worth $8,390,000 after purchasing an additional 3,242 shares during the period. US Bancorp DE bought a new position in shares of Arteris during the third quarter worth $34,000. Finally, Jacobs Levy Equity Management Inc. boosted its position in shares of Arteris by 36.3% during the third quarter. Jacobs Levy Equity Management Inc. now owns 253,211 shares of the company's stock worth $1,955,000 after purchasing an additional 67,414 shares in the last quarter. Institutional investors own 64.36% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Rosenblatt Securities reissued a "buy" rating and issued a $15.00 target price on shares of Arteris in a report on Wednesday, November 6th.

Get Our Latest Stock Report on AIP

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Stories

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ I want to send you my Cash Calendar (From Wealthpin Pro) (Ad)

Should you invest $1,000 in Arteris right now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?

AVGO is up 30% since earnings: could Broadcom be the next member of the Magnificent Seven? Can it sustain this momentum or is a pullback on the horizon?

Related Videos

Why Meta Is Still a Top Stock Pick for 2025
Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines